Shivalik Rasayan Ltd
Incorporated in 1979, Shivalik Rasayan Ltd is a manufacturer of Agrochemicals & Active Pharma Ingredients[1]
- Market Cap ₹ 855 Cr.
- Current Price ₹ 550
- High / Low ₹ 879 / 500
- Stock P/E 61.6
- Book Value ₹ 256
- Dividend Yield 0.09 %
- ROCE 4.44 %
- ROE 3.59 %
- Face Value ₹ 5.00
Pros
- Company is expected to give good quarter
- Debtor days have improved from 88.5 to 66.6 days.
Cons
- Promoter holding has decreased over last quarter: -0.58%
- Tax rate seems low
- Company has a low return on equity of 3.76% over last 3 years.
- Dividend payout has been low at 6.49% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
35 | 41 | 43 | 41 | 44 | 48 | 61 | 85 | 99 | 94 | 94 | 149 | |
33 | 38 | 38 | 34 | 36 | 42 | 51 | 66 | 76 | 74 | 77 | 123 | |
Operating Profit | 2 | 3 | 5 | 7 | 7 | 6 | 9 | 19 | 23 | 19 | 17 | 26 |
OPM % | 6% | 7% | 11% | 17% | 17% | 13% | 16% | 22% | 23% | 20% | 18% | 18% |
0 | 0 | 1 | 1 | 1 | 4 | 1 | 0 | 2 | 2 | 2 | 2 | |
Interest | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 6 | 5 | 5 | 5 | 9 |
Profit before tax | 2 | 3 | 4 | 5 | 6 | 9 | 9 | 13 | 19 | 15 | 10 | 14 |
Tax % | 34% | 33% | 33% | 33% | 19% | -3% | -0% | -1% | -3% | -3% | 15% | -3% |
1 | 2 | 3 | 3 | 5 | 9 | 9 | 13 | 19 | 15 | 9 | 14 | |
EPS in Rs | 1.37 | 2.10 | 3.10 | 3.84 | 4.84 | 6.47 | 6.35 | 9.20 | 13.36 | 10.42 | 5.55 | 8.91 |
Dividend Payout % | 0% | 0% | 0% | 10% | 8% | 8% | 4% | 5% | 4% | 5% | 9% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 20% |
3 Years: | 15% |
TTM: | 59% |
Compounded Profit Growth | |
---|---|
10 Years: | 23% |
5 Years: | 10% |
3 Years: | -11% |
TTM: | 61% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | -12% |
1 Year: | -3% |
Return on Equity | |
---|---|
10 Years: | 6% |
5 Years: | 5% |
3 Years: | 4% |
Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 4 | 7 | 7 | 7 | 7 | 7 | 8 | 8 |
Reserves | 6 | 8 | 10 | 14 | 42 | 153 | 161 | 173 | 266 | 284 | 366 | 390 |
0 | 0 | 11 | 14 | 8 | 9 | 0 | 11 | 15 | 40 | 55 | 61 | |
9 | 11 | 12 | 7 | 7 | 10 | 18 | 31 | 29 | 34 | 42 | 53 | |
Total Liabilities | 18 | 23 | 37 | 38 | 61 | 178 | 186 | 223 | 318 | 365 | 471 | 512 |
6 | 7 | 8 | 8 | 15 | 16 | 18 | 120 | 128 | 126 | 122 | 250 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 11 | 61 | 0 | 3 | 57 | 117 | 0 |
Investments | 0 | 0 | 16 | 18 | 27 | 27 | 39 | 53 | 55 | 65 | 73 | 74 |
12 | 16 | 13 | 12 | 19 | 124 | 68 | 49 | 131 | 117 | 159 | 188 | |
Total Assets | 18 | 23 | 37 | 38 | 61 | 178 | 186 | 223 | 318 | 365 | 471 | 512 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-1 | 4 | 6 | 4 | -2 | -12 | -7 | 46 | 7 | -13 | -1 | -1 | |
0 | -0 | -17 | -2 | -16 | -9 | -65 | -61 | -16 | -65 | -69 | -20 | |
0 | 1 | 7 | -2 | 19 | 104 | -9 | 10 | 76 | 21 | 83 | 22 | |
Net Cash Flow | -0 | 4 | -4 | 1 | 2 | 83 | -81 | -5 | 66 | -57 | 13 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 93 | 80 | 61 | 47 | 64 | 66 | 49 | 70 | 25 | 76 | 123 | 67 |
Inventory Days | 8 | 5 | 14 | 22 | 36 | 82 | 33 | 45 | 97 | 256 | 328 | 268 |
Days Payable | 103 | 126 | 139 | 76 | 66 | 92 | 166 | 119 | 108 | 154 | 102 | 114 |
Cash Conversion Cycle | -2 | -41 | -64 | -8 | 34 | 56 | -83 | -4 | 14 | 178 | 348 | 220 |
Working Capital Days | 17 | -11 | -40 | -37 | 38 | 169 | 202 | 33 | 97 | 212 | 251 | 187 |
ROCE % | 23% | 29% | 28% | 25% | 18% | 9% | 6% | 7% | 8% | 5% | 4% | 4% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
31 May - Newspaper Publication for the quarter and year ended results on 31.03.2025
-
Regulation 32- Statement Of Deviation
31 May - No deviation in utilization of ₹60.23 Cr preferential issue and ₹10.20 Cr warrant conversion funds.
-
Results For The Financial Year 31.03.2025
30 May - Approved audited FY25 results; final 10% dividend; new internal, cost, and secretarial auditors appointed.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Secretarial compliance report for FY 2024-25 confirms full regulatory adherence, no violations.
-
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Year Ended On 31.03.2025 And For Recommendation Of Final Dividend For The Year 2024-25
21 May - Board meeting on May 30 to approve FY25 results, dividend, and appoint auditors.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
SRL is the largest Indian producer of Dimethoate Technical and second largest Indian producer of Malathion Technical. It also manufactures organophosphorus-based insecticides and chemicals. Apart from this, company does development of Oncology and Non-Oncology active pharmaceutical ingredients and their finished dosage forms